Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 6, 2007, Pages 603-608

  Paccola, Letícia ^a   Jorge, Rodrigo ^a   Barbosa, José C ^b   Costa, Rogério A ^a,c   Scott, Ingrid U ^d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c Hospital de Olhos de Araraquara   (Brazil)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Drug delivery; Inflammation; Postoperative care; Prednisolone; Triamcinolone; Vitrectomy; Vitreous

Indexed keywords

CIPROFLOXACIN; CIPROFLOXACINA; EYE DROPS; OPHTHALMOS; PREDFORT; PREDNISOLONE ACETATE; STEROID; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTERIOR EYE CHAMBER; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CENTRAL RETINA ARTERY OCCLUSION; CHEMOSIS; CILIARY DISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; ECHOOCULOGRAPHY; EPIRETINAL MEMBRANE; ERYTHEMA; EYE INFLAMMATION; EYE PAIN; FEMALE; HUMAN; INFECTION; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MALE; OUTCOME ASSESSMENT; PERFORATING EYE INJURY; PHOTOPHOBIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA HOLE; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT DURATION; UVEA DISEASE; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 34548221967     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.00923.x     Document Type: Article

References (22)

1. Anecortave Acetate Clinical Study Group (2003): Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: 12-month clinical outcomes. Ophthalmology 110: 2372-2385.
2. Bakri SJ & Kaiser PK (2005): Posterior subtenon triamcinolone acetonide for refractory diabetic macular oedema. Am J Ophthalmol 139: 290-294.
3. Bonini-Filho MA, Jorge R, Barbosa JC, Calucci D, Cardillo JA & Costa RA (2005): Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular oedema: A randomized clinical trial. Invest Ophthalmol Vis Sci 46: 3845-3849.
4. Chalan KV, Malkani S & Shah AV (2003): Intravitreal dexamethasone effectively reduces postoperative inflammation after vitreoretinal surgery. Ophthalmic Surg Lasers Imaging 34: 188-192.
5. Ellis PP (1978): Occlusion of the central retinal artery after retrobulbar corticosteroid injection. Am J Ophthalmol 85: 352-356.
6. Fan DS, Lam DS, Ng JS, Yu CB, Wong CU & Cheung AY (2005): Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: A randomized trial. Clin Exp Ophthalmol 33: 252-258.
7. Flood TR, McManners J, el-Attar A & Moos KF (1999): Randomized prospective study of the influence of steroids on postoperative eye-opening after exploration of the orbital floor. Br J Oral Maxillofac Surg 37: 312-315.
8. Fuller JR, Bevin TH, Molteno AC, Vote BJ & Herbison P (2002): Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good longterm control of intraocular pressure without risk of sight-threatening complications. Br J Ophthalmol 86: 1352-1354.
9. Helm CJ & Holland GN (1995): The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 120: 55-64.
10. Hoffman RS, Fine IH & Packer M (2003): Incidence and outcomes of LASIK with diffuse lamellar keratitis treated with topical and oral corticosteroids. J Cataract Refract Surg 29: 451-456.
11. Krohn J (2003): Topical medication interferes with face-down positioning after macular hole surgery. Acta Ophthalmol Scand 81: 226-229.
12. Lafranco Dafflon M, Tran VT, Guex-Crosier Y & Herbort Carl P (1999): Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: Indications, efficacy and side-effects. Graefes Arch Clin Exp Ophthalmol 237: 289-295.
13. Lee H & Shah GK (2005): Intravitreal triamcinolone as primary treatment of cystoid macular oedema secondary to branch retinal vein occlusion. Retina 25: 551-555.
14. Morgan CM, Schatz H, Vine AK et al. (1988): Ocular complications associated with retrobulbar injections. Ophthalmology 95: 660-665.
15. Okada AA, Wakabayashi T, Morimura Y et al. (2003): Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol 87: 968-971.
16. Paganelli F, Cardillo JA, Melo LA Jr et al. (2004): A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Ophthalmology 111: 2102-2108.
17. Roman Guindo JM, Teus Guezala MA, Sanchez Pina JM et al. (2005): Evaluation of the efficacy of longterm topical steroid treatment to prevent regression after hyperopic LASIK. Arch Soc Esp Oftalmol 80: 13-18.
18. Solomon KD, Cheetham JK, DeGryse R et al. (2001): Topical ketorolac trimethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 108: 331-337.
19. Trinavarat A, Atchaneeyasakul LO, Surachatkumtonekul T & Kosrirukvongs P (2003): Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. J Med Assoc Thai 86: 143-150.
20. Winfield AJ, Jessiman D, Williams A & Esakowitz L (1990): A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 74: 477-480.
21. Yulek F, Ozdek S, Gurelik G & Hasanreisoglu B (2006): Effect of topical steroids on corneal epithelial healing after vitreoretinal surgery. Acta Ophthalmol Scand 84: 319-322.
22. Zamir E, Read RW, Smith RE et al. (2002): A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology 109: 798-807.